IL17A and diabetes mellitus: Similarly, weekly intraperitoneal injections of 50 μg/mL of anti-IL-17A significantly decreased (p < 0.05) diabetes-mediated IL-1β, IL-6, TNF-α, and ZO-1 degradation in the retinas of db/db-Type II diabetic mice 2 months post-diabetes.